Reportlinker Adds Global Nucleic Acid Testing Industry
NEW YORK, June 24 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Nucleic Acid Testing Industry
http://www.reportlinker.com/p0209257/Global-Nucleic-Acid-Testing-Industry.html
This report analyzes the Global market for Nucleic Acid Testing in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 46 companies including many key and niche players such as Abbott Laboratories, Inc., Agilent Life Sciences and Chemical Analysis, Applied Biosystems Group, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cepheid, Inc., Genomic Health, Inc., Gen-Probe Inc., Genzyme Corp., Genzyme Genetics, Myriad Genetics, Inc., Novartis AG, QIAGEN NV, Roche Diagnostics, Siemens Healthcare Diagnostics, Inc., and Third Wave Technologies, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
NUCLEIC ACID TESTING MCP-6070
A GLOBAL MARKET REPORT
CONTENTS
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Nucleic Acid Test I-3
Polymerase Chain Reaction or PCR Tests I-3
Reverse Transcriptase PCR or RT-PCR Tests I-3
Branched DNA or Quantiplex bDNA Tests I-3
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW II-1
Introduction II-1
Current and Future Analysis II-2
A Glance at the Nucleic Acid Testing Market II-2
Point of Care (POC) Nucleic Acid Tests II-2
Lateral Flow Platform-An Alternative to POC Nucleic Acid Testing II-3
2. MARKET TRENDS II-4
Veterinary Industry Eyes on Nucleic Acid Testing Kits and
Immunodiagnostics II-4
Home-Brewing Methods Continue to Dominate the NAPI Markets II-4
Molecular Diagnostics - A Largely Untapped Market II-4
Low-Priced Commercial Products to Mar the Popularity of
Conventional Nucleic Acid Isolation Methods II-5
Novel Applications and Technologies Widen Customer Base for
Nucleic Acid Isolation Processes II-5
FDA Licenses Nucleic Acid Tests Usage for Screening Hepatitis
C and HIV II-5
Usage of NAT for Screening Additional Categories of HIV in
Tissues and Donated Blood Approved by FDA II-6
3. PRODUCT OVERVIEW II-7
What is a Nucleic Acid Test? II-7
Polymerase Chain Reaction or PCR Tests II-7
Reverse Transcriptase PCR or RT-PCR Tests II-7
Branched DNA or Quantiplex bDNA Tests II-7
Applications of NAT II-7
NAT for Hepatitis C Virus Infection (HCV) II-7
Qualitative Tests II-8
Clinical Uses of Qualitative Nucleic Acid Test II-8
Quantitative Tests II-8
Real-Time PCR Method II-8
Use of NAA for Diagnosing Tuberculosis II-8
Factors Hindering the Adoptability of NAA Tests for
Tuberculosis II-9
Use of NAA for Diagnosing STI II-9
Use of Nucleic Acid Sequence-Based Amplification for
Diagnosing Dengue Viral RNA II-10
Segments of NAT Technology II-10
Amplified Probe Technology II-10
Signal Amplification II-10
Probe Amplification II-11
Target Amplification II-11
Direct Nucleic Acid Probes II-11
Types of Techniques II-11
In-situ hybridization (ISH) II-11
Southern Blot II-11
Liquid Hybridization II-11
Working Procedure of Nucleic Acid Tests II-11
Impediments for Using Technology II-11
Capturing Methods for Discovering Nucleic Acid Lateral Flow
(NALF) II-12
Multiplex Nucleic Acid Testing II-12
4. REGIONAL MARKET PERSPECTIVE II-13
4A. THE UNITED STATES II-13
A.Market Analysis II-13
Outlook II-13
A Snapshot of the US Nucleic Acid Testing Market II-13
Soaring Demand from Various Applications Drives the US NAPI
Market II-13
Use of NAT in STDs and HPV II-14
B.Market Analytics II-14
Table 1: US Recent Past, Current & Future Analysis for
Nucleic Acid Testing Markets with Annual Revenues in US$
Million for Years 2006 through 2015 (includes corresponding
Graph/Chart) II-14
4b. REST OF WORLD II-15
A.Market Analysis II-15
Outlook II-15
Overview of Select Regional Markets II-15
Europe II-15
A Glance at the Europe's Nucleic Acid Testing and Blood
Safety Market II-15
Table 2: European Recent Past, Current & Future Analysis
for Nucleic Acid-based Amplification Reagents Markets by
Geographic Region-France, Germany, Italy, UK, Spain and
Rest of Europe Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2006 through 2015
(includes corresponding Graph/Chart) II-16
Table 3: European 10-Year Perspective for Nucleic
Acid-based Amplification Reagents by Geographic Region -
Percentage Breakdown of Revenues for France, Germany,
Italy, UK, Spain and Rest of Europe Markets for 2006, 2009 &
2015 (includes corresponding Graph/Chart) II-17
Table 4: European Recent Past, Current & Future Analysis
for Nucleic Acid-based Amplification Reagents by Segment-
Genetic Testing, Infectious Diseases and Transplant
Diagnostics Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2006 through 2015
(includes corresponding Graph/Chart) II-18
Table 5: European 10-Year Perspective for Nucleic
Acid-based Amplification Reagents by Segment - Percentage
Breakdown of Revenues for Genetic Testing, Infectious
Diseases and Transplant Diagnostics Markets for 2006, 2009 &
2015 (includes corresponding Graph/Chart) II-18
China II-19
Chinese Nucleic Acid Testing Market: An Overview II-19
B.Market Analytics II-19
Table 6: Rest of World Recent Past, Current & Future
Analysis for Nucleic Acid Testing Markets with Annual
Revenues in US$ Million for Years 2006 through 2015
(includes corresponding Graph/Chart) II-19
5. PRODUCT LAUNCHES II-20
DaAn Gene Unveils Nucleic Acid Testing Kit for Influenza A
H1N1 Virus II-20
Sequenom Launches SensiGene Cystic Fibrosis Carrier Screening
Test II-20
Jeevan Introduces Nucleic Acid Testing II-20
6. STRATEGIC CORPORATE DEVELOPMENTS II-21
Gen-Probe Acquires Prodesse II-21
STRATEC Takes Over Invitek II-21
Becton, Dickinson and Company Takes Over Handy Lab II-21
Gen-Probe Acquires Tepnel Life Sciences II-21
Micronics and Biosearch Technologies Ink Licensing Agreement II-22
Quidel and BioHelix Sign Agreement II-22
BlueGnome Signs Agreement with Rubicon Genomics II-22
DaAn Gene to Setup Four Joint Ventures II-23
Gen-Probe and Chiron to Extend Partnership II-23
EnviroLogix Inks Licensing Agreement with Ionian Technologies II-23
HandyLab Extends Partnership with Epoch Biosciences II-24
QIAGEN to Provide Molecular Testing Solutions to Bio-Manguinhos II-24
Nanogen Signs Licensing and Supply Agreement with HandyLab II-24
Blood System Laboratories and Florida Blood Services Establish
a Joint Venture II-25
Teva Collaborates with Compugen II-25
QIAGEN Takes-Over Biotage's Biosystems Unit II-25
QIAGEN Snaps Up Corbett Life Science II-25
Agilent Technologies to Expand API Manufacturing Plant II-25
Polyclone Bioservices to Establish Nucleic Acid Testing Units
in India II-26
Pacgen Biopharmaceuticals Signs LoI with Medigen Biotechnology II-26
easyDNA Establishes New DNA Testing Center in India II-26
Apollo Chennai Establishes Nucleic Acid Testing Unit II-26
7. OTHER DEVELOPMENTS II-27
Nanosphere Receives FDA Approval for Respiratory Virus Assay II-27
Roche Diagnostics Obtains FDA Approval for Broader Usage of
Nucleic Acid Test II-27
US and European Patent Authorities Award Patents to Gen-Probe
for NAT II-27
The National Institute of Allergy and Infectious Diseases
Awards $770,000 to Micronics II-28
DaAn Gene Obtains SFDA Approval for Marketing Nucleic Acid
Test Kits II-28
Luminex Molecular Diagnostics xTAG Respiratory Viral Panel
Approved by FDA II-28
Siemens Healthcare's Apple iMac OSX Operating System Approved
by FDA II-28
Micronics Receives NIH Grant for Developing HIV POC Test II-28
8. FOCUS ON SELECT PLAYERS II-29
Abbott Laboratories, Inc. (US) II-29
Agilent Life Sciences and Chemical Analysis (US) II-29
Applied Biosystems Group (US) II-29
Becton, Dickinson and Company (US) II-30
Bio-Rad Laboratories, Inc. (US) II-30
Cepheid, Inc. (US) II-31
Genomic Health, Inc. (US) II-31
Gen-Probe Inc. (US) II-31
Genzyme Corp. (US) II-32
Genzyme Genetics (US) II-32
Myriad Genetics, Inc. (US) II-33
Novartis AG (Switzerland) II-33
QIAGEN NV (Netherlands) II-33
Roche Diagnostics (US) II-34
Siemens Healthcare Diagnostics, Inc. (US) II-34
Third Wave Technologies, Inc. (US) II-34
9. GLOBAL MARKET PERSPECTIVE II-35
Table 7: World Recent Past, Current & Future Analysis for
Nucleic Acid Testing by Geographic Region - US and Rest of
World Markets Independently Analyzed with Annual Revenues in
US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart) II-35
Table 8: World 10-Year Perspective for Nucleic Acid Testing by
Geographic Region -Percentage Breakdown of Revenues for US and
Rest of World Markets for 2006, 2009 & 2015 II-35
III. COMPETITIVE LANDSCAPE
Total Companies Profiled: 46 (including Divisions/Subsidiaries - 49)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 34
Canada 3
Europe 6
France 1
Germany 1
The United Kingdom 1
Rest of Europe 3
Asia-Pacific (Excluding Japan) 4
Latin America 1
Middle-East 1
------------------------------------------
To order this report:
Diagnostics Industry: Global Nucleic Acid Testing Industry
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article